Loading

Archives of Emergency Medicine and Critical Care

The Importance of Electrolyte Management in Rural Tele-Intensive Care

Review Article | Open Access | Volume 1 | Issue 1

  • 1. Department of Internal Medicine, University of South Dakota Sanford School of Medicine, USA
+ Show More - Show Less
Corresponding Authors
Edward T. Zawada, Department of Internal Medicine, University of South Dakota Sanford School of Medicine, Shasta Critical Care Specialists, 2701 Eureka Way, Redding, California, 96001, USA Tel: (605) 360-1206
Absract

Our tele-intensivist program has been recognized for uniquely providing supervision of seriously ill hospitalized patients for nearly nine years to one of the most sparsely populated six-state region of the North Central United States. We are currently monitoring 133 patients in thirty-three hospitals. A staff of one intensivist, two critical care nurses, and an information technician see on average 22.1 admissions per day and perform 925 interventions per month. The third most numerous interventions classified as major by the intensivist was that of severe electrolyte disturbances requiring correction. This was considered as major a problem as diagnosing and managing hypotension and respiratory failure which were the top two most common interventions. For those considered intermediate or minor to the care plan of the patient, electrolyte correction was second to communication with families and providers. Discussed in this report will be a review of recent literature suggesting the importance to prognosis and outcomes of critically ill patients of correction of such electrolyte disturbances. We conclude that these high numbers of successful interventions which contributes to a high throughput of patients monitored each day reflects the welcome acceptance of teleintensive care to rural hospitals.

Citation

Zawada ET (2016) The Importance of Electrolyte Management in Rural Tele-Intensive Care. Arch Emerg Med Crit Care 1(1): 1003.

Keywords

Electrolyte, Tele-intensive care, Ventilation

INTRODUCTION

History and evolution of Avera eCare™

The Avera Health System launched its telemedicine program by offering consultation by televideo connectivity from the main tertiary hospital in the largest city of the multi-state North Central Region of the United States. The major growth spurt in our rural telehealth program came after the initiation of tele-intensive care called eICU Care® in 2004. Since then multiple other tele-health programs have been initiated and then quickly expanded by demand for additional services.

In a previously published report we described the consequences of our eICU [1]. The project initially started with the tertiary hospital serving as the hub providing twenty-four hour video monitoring and remote patient care of three mediumsized rural hospitals. It evolved to include several more hospitals of that size called “rural regional hospitals.” Additionally, more remote “critical access” (20 beds or less) hospitals began to request the coverage. Tele-intensivist supervision further expanded to hospitals outside of our own health system and those with different medical record or electronic record systems. Finally, it expanded to patient supervision in multiple states.

Current status of Avera eICU Care™

Avera eCare® now has had several years of experience providing multiple additional telehealth services. These programs have each enjoyed the same growth. After tele-consultation and tele-intensive care, the next phase included the birth and then rapid expansion of programs such as our Emergency, eStroke, and ePharmacy. In several of these, the number of sites exceed the number of eICU services. This could be the result of several factors, but one could postulate that perhaps these services have been more useful to rural sites of care. Now even more varied eServices have been born such as eLong-Term Care and eUrgent Care/Prisons, providing care to an amazing assortment of doctors, clinics, hospitals, and other health care facilities. Since theseservices have been launched, they each have been received beyond expectations. As time progresses and needs arise, unique applications of telemedicine supervision are being developed. Many of these are in the pilot stages in our comprehensive program. Our multiple telehealth services are now largely sustained by internal funding. The start-up portions are usually supported, in part, by grants. With this support we have been able to develop a “headquarters” for all of our multiple telehealth services as a unique service line geographically located in one location

Contribution of Avera eICU Care™ to quality of care outcomes

After implementation of our tele-intesive care program we were able to compare outcomes to that prior to the program [1]. In the rural setting we improved intensive care unit length of stay and had reduced mortality. We reduced days on mechanical ventilation. These improvements carried forth to the entire hospital stay. We demonstrated reduced length of total hospital stay, and reduced total hospital mortality. We have monitored and improved compliance with best practices such as deep vein thrombosis prevention and gastrointestinal tract ulcer prevention. Finally, we surveyed our participating hospitals and estimated the number of cases that remained local to their initial hospital who otherwise would have been transferred to the tertiary care hospital. From that information we identified over a milliondollars of reduced costs for ground and especially air transport.

The importance of electrolyte correction, acid base management and correction of metabolic disorders by tele-intensive care

There are nearly fifty tele-intensive care programs in the United States today. Our program has consistently had the highest number of interventions per month. At the end of an intervention, the intensivist classifies the action as major, intermediate, or minor. The ten most common major interventions over a fiveyear period from January 1, 2008 until December 31 2012 in descending order included hypotension, respiratory failure evaluation and management, electrolyte abnormality, airway management, acid-base disturbances, hyperglycemia with active titration of insulin therapy, arrhythmia diagnosis and treatment, sepsis evaluation and treatment, acute renal failure management, and shock evaluation and treatment. The complete list of major interventions is shown in Table 1.

Table 1: Complete list of major interventions

  eICU Interventions                       
VISICU Avera Health 1/1/2008 to 12/31/2012
Interventions By Class
Major Total Comments
Other 3806  
Hypotension – evaluation and management 2091  
Respiratory failure – evaluation and management 1666  
Electrolyte abnormality – evaluation and management 1621  
Airway management 1460  
Acid-Base disturbance – evaluation and management 1264  
Hyperglycemia – active titration of insulin therapy 1264  
Arrhythmia – evaluation and management 1068  
Sepsis – evaluation and management 1033  
Hypoxemia – evaluation and management 868  
Acute renal failure – evaluation and management 787  
Shock – evaluation and management 701  
Hypertension – evaluation and management 459  
Delirium, psychosis, severe agitation – evaluation and management 397  
End of life/care limitation discussion 377  
Change in mental status – evaluation and management 362  
Infection – evaluation and management 305  
Hypotension – initiation/titration of pressors/inotropes 219  
Hemorrhage – evaluation and management 188  
Hypovolemia – evaluation and treatment with fluids 180  
Hypercarbia – evaluation and management 167  
Code management/supervision 152  
Seizures – evaluation and management 115  
Sepsis – severe evaluation and management 69  
Procedure – evaluation and supervision 56  
Shock – evaluation and treatment with pressors/inotropes 55  
Operative interventional procedure – evaluation 49  
Intracranial hypertension – evaluation and management 18  
Adrenal insufficiency – evaluation and management 14  
                                                   Major Total 20811  

The interventions considered by the tele-intensivist as intermediate interventions includecommunication with other health care providers and/or family, electrolyte abnormality diagnosis and management, hyperglycemia evaluation and treatment, best-practice implementation (deep vein thrombosis prophylaxis, beta-blocker therapy, etc.), and diagnostic test evaluation in that order. Electrolyte and glucose surveillance and treatment were second only to communication with health care providers or family. The most common minor interventions included communication with other healthcare providers and/ or family, routine modification to the care plan (i.e. medications for pain or fever), clinical assessment leading to ordering of diagnostic tests, agitation and anxiety diagnosis and treatment, and electrolyte abnormality evaluation and management. Table 2 below shows the complete list of intermediate and minor interventions.

Table 2: Complete list of intermediate and minor interventions.

                                                eICU Interventions
VISICU Avera Health 1/1/2008 to 
12/31/2012
Intermediate Total Comments
Communication with other healthcare providers and/or family 6725  
Electrolyte abnormality – evaluation and management 5982  
Hyperglycemia – evaluation and treatment 5664  
Best-practice therapies (e.g. DVT, beta blocker, etc.) 5279  
Other 5269  
Diagnostic test evaluation 2200  
Arrhythmia – evaluation and management 2031  
Hypotension – evaluation and management 1947  
Respiratory distress – evaluation and management 1859  
Pain – evaluation and management 1375  
Oliguria – evaluation and management 1348  
Hypertension – evaluation and management 954  
Bleeding – evaluation and treatment with blood products 867  
Medication change / dose adjustment 848  
Hypotension – evaluation and treatment with fluids 741  
Infection – evaluation and management 695  
Hypovolemia – evaluation and management 347  
Coagulopathy – evaluation and management 272  
Hypervolemia – evaluation and management 209  
Change in mental status – evaluation and management 132  
Abdominal pain – evaluation and management 59  
Thrombocytopenia – evaluation and management 40  
Bronchospasm – evaluation and treatment 37  
                                                              Intermediate Total 44880  
Minor Total Comments
Communication with other healthcare providers and/or family 6680  
Routine modifications to care plan (e.g. PRN medications for pain, fever) 3175  
Clinical assessment – ordering diagnostic tests 1235  
Other 1230  
Agitation/anxiety – evaluation and management 1175  
Electrolyte abnormality – evaluation and management 961  
                                                                           Minor Total 14456

Review of recent literature concerning the impact of electrolyte abnormalities on outcomes in critically ill patients

 Every year, a smattering of reports document the impact of abnormalities of electrolytes on hospital length of stay, hospital mortality, intensive care unit admission rates and intensive care unit outcomes. A brief review of several years of these reports will now be presented. A recent study involving 151,486 adult patients from 77 intensive care units over a period of ten years demonstrated that many cases of dysnatremia are acquired in the intensive care unit, and that the severity of dysnatremia is associated with poor outcome in a graded fashion [2]. In 2009 Callahan and others [3] reported that the most common electrolyte abnormality seen in general hospital patients in the United States varying from 1-6% in multipleseries is hyponatremia. Admissions with hyponatremia resulted in an average two days longer length of stay, contributing $3,540 per case. When multiplied times the number of admissions with this electrolyte disorder over a year at a single academic-setting hospital, the total cost of this problem was over a million dollars. Extrapolating to the country at large, they predicted over a billion dollars in additional costs for health care delivery (Figures 1, 2).

Shows the total number of major, intermediate, and minor interventions.

Figure 1: Shows the total number of major, intermediate, and minor interventions.

Illustrates the relationship of the electrolyte interventions to the total major, intermediate, and minor interventions.

Figure 2: Illustrates the relationship of the electrolyte interventions to the total major, intermediate, and minor interventions.

In a very recent publication Leung and others reported on the impact of sodium disorders on surgical patients [4]. This was the American College of Surgeons National Quality Improvement Database.In this report, the authors reviewed the 30 day perioperative outcomes in 964,263 adults going to surgery in >200 hospitals from 1/1/2005 to 12/3/2013. They looked at 30 day perioperative outcomes. 75,423 had serum sodium < 135 mEq. They had 44% increased death rate. There was higher 30 day mortality. There were increased perioperative coronary events, wound infections, and pneumonia. Length of stay was increased by 1 full day. Tele-intensive care is suited to the prevention of these disorders of sodium and subsequent poor surgical outcomes.In 2011 Yunosdescribed the importance of reducing chloride rich fluids (normal saline) in consecutive patients admitted to a large multidisciplinary Australian hospital over a six month period of time which prevented hospitalacquired metabolic acidosis and severe acidemia [5]. A teleintensive care program which provides 24-hour supervision of patients can assist with strategies to ensure use of reduced chloride-rich fluids.

Most clinicians are keenly aware of the impact of major disorders of serum potassium and subsequent outcomes in seriously ill patients. However, a 2012 report [6] suggested that even small deviations of serum potassium from normal had consequences to outcomes after myocardial infarction. In this report the Cerna Health Facts Database was studied. 38,689 patients with acute myocardial infarction in 67 hospitals were reviewed from 1/1/2000 until 12/31/2008. There were two times the mortality in those 4.5 – 5.0 or < 3.5 than those 3.5-4.5 mEq/L. The abnormal values were associated with ventricular fibrillation or cardiac arrest. Tele-intensive care can keep a very close watch on serum potassium to maintain such a narrow normal range.

Disorders of calcium [7] and magnesium [8] have been reported to be quite frequent in intensive care unit patients. Cardiovascular instability, prolonged ventilator support, and higher mortality have been seen in such patients. Low ionized serum calcium is found in 15-20% of critically ill patients and has been associated with increased mortality in the intensive care unit [9,10]. In areport by Attur and associates in 110 patients in a single ICU, serum calcium negatively correlated with APACHE II score and subsequent mortality [11]. In a 2011 report from April to May 2005, patients in Mumbai were reviewed [8]. Those with low serum magnesium had about two extra intensive care unit days. There was longer mechanical ventilation by ~ 2 days. There was twice the mortality despite similar APACHE scores. Serum magnesium is easily monitored and replaced by a telemedicine service. Finally, the prevalence of hypophosphatemia is high in the intensive care unit, about 28% of critically ill patients [12]. Hypophosphatemia is associated with leukocyte, erythrocyte, and platelet dysfunction. In addition, hypophosphatemia has been reported to be responsible for clinical syndromes of muscular weakness, confusion, ataxia, seizures and coma, respiratory failure, cardiacarrhythmias, and cardiomyopathy. We frequently replace serum phosphorus in our telemedicine intensive care program

Illustrative case report

An 81 year old female with a prior history of diverticulosis and chronic kidney disease presented to a rural hospital with abdominal discomfort which had started the night before. She presumed it was related to herchronic constipation. She took capfuls of milk of magnesia which failed to give her relief. At presentation to the hospital she had fever and elevated white blood count and serum magnesium level. Before transfer her exam revealed an irregularly irregular heart rhythm, clear lungs, and a soft abdomen which was non-tender. She had edema. Her lab tests revealed a serum creatinine of 2.2 mg/dL and a serum magnesium level of 7.4 mg/dL. X-ray revealed ileus. Under the direction of our teleintensive care service, she was given intravenous fluids but the serum magnesium did not decrease (Table 3).

Table 3: Shows these initial lab abnormalities.

  4/28/13
06:25
4/28/13
06:26
4/28/13
11:35
4/28/13
15:30
4/28/13
15:30
Sodium 135       134
Potassium 4.3       4.3
Chloride 99       100
Carbon Dioxide 26       25
POC Total CO2          
Anion Gap 10       9
BUN 57 H       56 H
Creatinine 2.2 H       2.4 H
GFR Calculation 21        
BUN/Creatinine Radio 25.9 H       23.3 H
Glucose 152 H       143 H
POC Glucose          
Lactic Acid       1.5  
Calcium 10.2       9.0
POC WB Ioniz Calcium          
Phosphorus   6.6H      
Magnesium   7.4H 6.5H    
Iron          
TIBC          
% Saturation          
Unsat Iron Binding          
Ferritin          
Total Bilirubin 0.4        
Direct Bilirubin          
Indirect Bilirubin          
AST 34H        
ALT 27        
Alkaline Phosphatase 76        
C-Reactive Pro, Quant          
B-Natriuretic Peptide 194H        
Total Protein 6.1        
  4/28/13
06:25
4/28/13
06:26
4/28/13
11:35
4/28/13
15:30
4/28/13
15:30
Sodium 135       134
Potassium 4.3       4.3
Chloride 99       100
Carbon Dioxide 26       25
POC Total CO2          
Anion Gap 10       9
BUN 57 H       56H
Creatinine 2.2 H       2.4 H
GFR Calculation 21        
BUN/Creatinine Radio 25.9 H       23.3 H
Glucose 152 H       143 H
POC Glucose          
Lactic Acid       1.5  
Calcium 10.2       9.0
POC WB Ioniz Calcium          
Phosphorus   6.6 H      
Magnesium   7.4 H 6.5 H    
Iron          
TIBC          
% Saturation          
Unsat Iron Binding          
Ferritin          
Total Bilirubin 0.4        
Direct Bilirubin          
Indirect Bilirubin          
AST 34 H        
ALT 27        
Alkaline Phosphatase 76        
C-Reactive Pro, Quant          
B-Natriuretic Peptide 194 H        
Total Protein 6.1        

The patient quickly deteriorated and was noted to have mental lethargy, acute worsening of renal function, pulmonary congestion/pneumonia, and worsening ileus. She was treated with broad spectrum antibiotics for possible GI or pulmonary sources of infection. However, it was felt by our tele-intensivist service that the patient was deteriorating in part from thesustained high level of serum magnesium (magnesium toxicity), especially her altered mental status and worsening ileus. A joint decision was made between our tele-intensivist and the primary physician to transfer the patient to our tertiary care facility for initiation of dialysis to further manage hypermagnesemia which was causing or complicating the obstipation, stupor, and subacute diverticulitis.

After transfer to our tertiary care facility dialysis was initiated which surprisingly also failed to definitively lower serum magnesium levels. Dialysis was performed daily for 2-3 hours. Levels were reduced but then boomeranged by the next hospital day. The serum magnesium levels were elevated with each day’s morning lab tests, and her obtundation and ileus persisted (Table 4).

Table 4: Below demonstrates the recurrently elevated morning magnesium levels despite lowering during daily dialysis.

  4/27/13
12:45
4/27/13
18:30
4/27/13
21:50
4/28/13
01:00
4/28/13
05:48
Sodium          
Potassium          
Chloride          
Carbon Dioxide          
POC Total CO2          
Anion Gap          
BUN          
Creatinine          
GFR Calculation          
BUN/Creatinine Radio          
Glucose          
POC Glucose          
Lactic Acid         147 H
Calcium          
POC WB Ioniz Calcium          
Phosphorus          
Magnesium 5.4 H 5.9 H 6.6 H 7.1 H  
Iron          
TIBC          
% Saturation          
Unsat Iron Binding          
Ferritin          
Total Bilirubin          
Direct Bilirubin          
Indirect Bilirubin          
AST          
ALT          
Alkaline Phosphatase          
C-Reactive Pro, Quant          
B-Natriuretic Peptide 215 H        
Total Protein          

Finally, with the use of multiple non-magnesium containing cathartics and enemas, she had multiple large volumes of stools. At first the texture was stony hard, later soft, and still later watery. Her serum magnesium now fell to normal levels (Tables 5, 6, 7).

Table 5: Flowsheet of the resolution of the hypermagnesemia without further hemodialysis when the catharsis was successful.

  4/30/13
07:10
4/30/13
07:10
4/30/13
07:10
4/30/13
16:34
4/30/13
16:34
Sodium 133        
Potassium 4.2     3.4 L  
Chloride 100        
Carbon Dioxide 22        
POC Total CO2          
Anion Gap 11        
BUN 49 H        
Creatinine 2.8 H        
GFR Calculation          
BUN/Creatinine Radio 17.5        
Glucose 143 H        
POC Glucose          
Lactic Acid          
Calcium 8.0 L        
POC WB Ioniz Calcium         0.97 L
Phosphorus 4.4     2.4 L  
Magnesium 5.3 H     3.6 H  
Iron          
TIBC          
% Saturation          
Unsat Iron Binding          
Ferritin          
Total Bilirubin          
Direct Bilirubin          
Indirect Bilirubin          
AST          
ALT          
Alkaline Phosphatase          
C-Reactive Pro, Quant          
B-Natriuretic Peptide     343 H    
Total Protein          

Table 6: Flowsheet of the resolution of the hypermagnesemia without further hemodialysis when the catharsis was successful

  5/2/13
21:36
5/3/13
03:45
5/4/13
05:04
5/5/13
04:53
5/5/13
04:53
Sodium   136 139 142  
Potassium 3.4 L 3.9 3.2 L 3.3 L  
Chloride   99 102 104  
Carbon Dioxide   29 25 27  
POC Total CO2          
Anion Gap   8 12 11  
BUN   42 H 35 H 32 H  
Creatinine   0.9 0.8 0.8  
GFR Calculation   >60   >60  
BUN/Creatinine Radio   46.7 H 43.8 H 40.0 H  
Glucose   98 113 H 106  
POC Glucose          
Lactic Acid          
Calcium   8.6 8.3 L 8.0 L  
POC WB Ioniz Calcium          
Phosphorus 3.9 3.7   3.5  
Magnesium 2.9 H 2.7 H      
Iron          
TIBC          
% Saturation          
Unsat Iron Binding          
Ferritin          
Total Bilirubin         0.2
Direct Bilirubin         0.0
Indirect Bilirubin         0.0
AST         0.2
ALT         28
Alkaline Phosphatase         14
C-Reactive Pro, Quant         61
B-Natriuretic Peptide          
Total Protein         5.7 L

Table 7: Flowsheet of the resolution of the hypermagnesemia without further hemodialysis when the catharsis was successful.

  5/6/13
05:18
5/7/13
05:19
5/8/13
05:43
5/9/13
05:18
5/10/13
07:05
Sodium 143 140   138 139
Potassium 3.3L 3.9 4.0 4.3 3.9
Chloride 108 H 107   108 H 109 H
Carbon Dioxide 25 24   21 22
POC Total CO2          
Anion Gap 10 9   9 8
BUN 23 16   13 15
Creatinine 0.7 0.8   0.8 0.8
GFR Calculation > 60 >60      
BUN/Creatinine Radio 32.9 H 20.0   16.3 18.8
Glucose 112 H 109   113 H 107
POC Glucose          
Lactic Acid          
Calcium 8.0 L 8.0 L   8.5 8.2 L
POC WB Ioniz Calcium          
Phosphorus 2.7 2.9 3.1    
Magnesium 1.8   1.9    
Iron          
TIBC          
% Saturation          
Unsat Iron Binding          
Ferritin          
Total Bilirubin          
Direct Bilirubin          
Indirect Bilirubin          
AST          
ALT          
Alkaline Phosphatase          
C-Reactive Pro, Quant          
B-Natriuretic Peptide          
Total Protein          

Once the serum magnesium was consistently reduced, her overall clinical status markedly improved, mental status, pulmonary status (extubated), renal function, and finally the ileus resolved

The patient was discharged home to finish a course of antibiotics for diverticulitis and pneumonia. She was given instructions to avoid magnesium-containing antacids and cathartics. It was concluded that the GI impaction served as a reservoir for magnesium making the levels rebound even after dialysis. We suggest that this case illustrates the potential impact of hypermagnesemia on critically ill patients, worsening ICU length of stay and time on a ventilator, and requiring hemodialysis for acute symptom control. In addition the case demonstrates the interaction between our tele-intensivist program in assisting the rural practitioner

SUMMARY AND CONCLUSIONS

In summary, we have described our unique rural telemedicine service line. We presented data on the usual workload of our program which services the North Central region of the United States. Electrolyte surveillance and correction is one of the most common and important interventions made by our team. Finally, a review the literature with respect to the impact of electrolyte disorders on morbidity and mortality and such quality outcomes such as ICU and hospital length of stay was presented along with an illustrative case.

In conclusion, a quick summary of the salient features of this report is presented below:

Top Ten Features of the Workload of the Most Rural Teleintensivist Care Program

1. Our tele-intensivist program is considered the most rural of similar programs in the USA.

2. We monitor 133 beds in 33 hospitals across a 6 state area.

3. Our program has been operating for 108 months.

4. The program increases throughput such that there are a high number of admissions per day.

5. Our program has the highest number of interventions per month (925).

6. Electrolyte management, acid-base surveillance and correction, and glucose control are the most frequent interventions across three categories of major, intermediate, and minor interventions.

7. Tele-intensivist care is an active, welcome, and needed service in the rural setting.

8. A rural environment likely has the most acceptance of input from a tele-intensivist service to improve quality measures in rural hospitals in a cost-effective manner.

9. Decisions as to when to transfer a patient to the tertiary care center can be a coordinated effort between the teleintensivist and the primary care rural provider to facilitate transfer and to be sure transfer occurs in a timely rather than delayed manner.

10. The tele-intensivist service can provide expertise to keep many patients locally to avoid the large cost of ground or especially air transfer.

A critique of this report is that it is a purely descriptive work. The conclusions above are not based on proving a hypothesis. The goal of the information presented here is to catalogue and quantitate the daily work of intensivists managing seriously ill patients by telemedicine. Managing electrolytes is among the most common tasks performed repeatedly by the telemedicine staff. A brief review of several articles which have shown improved patient outcomes by electrolyte management is presented to suggest that the same would be true in these telemedicine efforts. Finally, an actual illustrative case report is presented reviewing the interaction of the rural tele-intensive care hub or center in the management of a severe electrolyte disorder (hypermagnesemia) in the patient at the rural site. The interaction led to transfer to the tertiary medical center for dialysis to correct the disorder and subsequent physiological consequences.

CONFLICTS OF INTEREST

The author declares no conflict of interest. The author wishes to thank the staff of physicians, nurses, and information clerks of the Avera eICU Care™ (T) program for the many years of dedication to advancing telehealth to the North Central region of the United States.

REFERENCES

1. Zawada Jr. ET, Herr P, Larson D, Fromm R, Kapaska D, Erickson D. Impact of an ICU telemedicine program on a rural health system. Postgrad Med. 2009; 121: 160-170.

2. Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010; 36: 304-311.

3. Callahan MA, Do HT, Caplan DW, Yoon-Flannery K. Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad Med. 2009; 121: 186-191.

4. Leung AA, McAlister FA, Rogers SO Jr, Pazo V, Wright A, Bates DW. Preoperative hyponatremia and perioperative complications. Arch. Intern Med. 2012; 172: 1474-1481.

5. Yunos NM, Kim IB, Bellomo R, Bailey M, Ho L, Story D, et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med. 2011; 39: 2419-2424.

6. Goyal A, Spertus JA, Gosch K, Venkitachalam L, Jones PG, Van den Berghe G, et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA. 2012; 307: 157-164.

7. Kelly A, Levine MA. Hypocalcemia in the critically ill patient. J Intensive Care Med. 2013; 28: 166-177.

8. Limaye CS, Londhey VA, Nadkart MY, Borges NE. Hypomagnesemia in critically ill medical patients. J Assoc Physicians India. 2011; 59: 19- 22.

9. Zaloga GP. Hypocalcemia in critically ill patients. Crit Care Med. 1992; 20: 251-262. 10.Spahn DR. Hypocalcemia in trauma: frequent but frequently undetected and underestimated. Crit Care Med. 2005; 33: 2124-2125.

11. Attur RP, Wagas WB, Prakash K.The APAPCHE II score and mortality in relation to hypocalcemia incritically ill patients. Journal of Clinical and Diagnostic Research. 2011; 5: 708-710.

12. Bugg NC, Jones JA. Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia. 1998; 53: 895- 902.

Zawada ET (2016) The Importance of Electrolyte Management in Rural Tele-Intensive Care. Arch Emerg Med Crit Care 1(1): 1003.

Received : 31 Mar 2016
Accepted : 01 Jun 2016
Published : 02 Jun 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X